Mitoxana en es it fr

Mitoxana Brand names, Mitoxana Analogs

Mitoxana Brand Names Mixture

  • No information avaliable

Mitoxana Chemical_Formula

C7H15Cl2N2O2P

Mitoxana RX_link

http://www.rxlist.com/cgi/generic2/ifosfamide.htm

Mitoxana fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=95

Mitoxana msds (material safety sheet)

Mitoxana MSDS

Mitoxana Synthesis Reference

No information avaliable

Mitoxana Molecular Weight

261.085 g/mol

Mitoxana Melting Point

39-41 oC

Mitoxana H2O Solubility

3780 mg/L

Mitoxana State

Solid

Mitoxana LogP

-0.01

Mitoxana Dosage Forms

Powder for constitution and administration by intravenous infusion

Mitoxana Indication

For third line chemotherapy of germ cell testicular cancer. It should ordinarily be used in combination with a prophylactic agent for hemorrhagic cystitis, such as mesna.

Mitoxana Pharmacology

Ifosfamide selectively inhibits the synthesis of deoxyribonucleic acid (DNA). The guanine and cytosine content correlates with the degree of ifosfamide-induced cross-linking. At high concentrations of the drug, cellular RNA and protein synthesis are also suppressed.

Mitoxana Absorption

No information avaliable

Mitoxana side effects and Toxicity

LD50 (mouse) = 390-1005 mg/kg, LD50 (rat) = 150-190 mg/kg. Side effects include nausea, vomiting and myelosuppression. Toxic effects include central nervous system toxicity (confusion, hallucinations) and urotoxic effects (cystitis, blood in urine).

Mitoxana Patient Information

No information avaliable

Mitoxana Organisms Affected

Humans and other mammals